However, CCL4 was increased in BALF samples from patients with corticosteroid resistant asthma [29], and treatment with dupilumab is recommended for oral corticosteroid-dependent severe asthma [7,21,30,31], consistent with our findings. Here, CCL4 is linked to asthma.